Free Trial

Glaukos Q3 2023 Earnings Report

Glaukos logo
$82.57 -4.43 (-5.09%)
As of 01:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Glaukos EPS Results

Actual EPS
-$0.50
Consensus EPS
-$0.56
Beat/Miss
Beat by +$0.06
One Year Ago EPS
-$0.45

Glaukos Revenue Results

Actual Revenue
$78.05 million
Expected Revenue
$75.25 million
Beat/Miss
Beat by +$2.80 million
YoY Revenue Growth
+9.50%

Glaukos Announcement Details

Quarter
Q3 2023
Time
After Market Closes

Conference Call Resources

Conference Call Audio

Remove Ads

Glaukos Earnings Headlines

Trump to unlock 15-figure fortune for America (May 3rd) ?
We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.
See More Glaukos Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Glaukos? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Glaukos and other key companies, straight to your email.

About Glaukos

Glaukos (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

View Glaukos Profile

More Earnings Resources from MarketBeat